Brain Region Disease Involvement

Overview

This page maps neurodegenerative diseases to the brain regions they primarily affect, providing a comprehensive reference for understanding regional vulnerability in Alzheimer's disease, Parkinson's disease, and related disorders. Understanding which brain regions are affected by each disease is fundamental to comprehending clinical presentations, disease progression patterns, and the development of targeted therapies. [@braak2003]

Overview

This page maps neurodegenerative diseases to the brain regions they primarily affect, providing a comprehensive reference for understanding regional vulnerability in Alzheimer's disease, Parkinson's disease, and related disorders. Understanding which brain regions are affected by each disease is fundamental to comprehending clinical presentations, disease progression patterns, and the development of targeted therapies. [@braak2003]

Neurodegenerative diseases exhibit characteristic patterns of regional brain involvement that distinguish them from one another and contribute to their unique clinical phenotypes. These patterns reflect the underlying molecular pathology and spread of disease through anatomically connected neural networks. This mapping provides a quick reference for researchers, clinicians, and students seeking to understand the neuroanatomical basis of neurodegenerative disease. [@jellinger2003]

--- [@hornykiewicz2010]

Alzheimer's Disease

Alzheimer's disease (AD) follows a characteristic pattern of progression that begins in limbic structures and spreads to cortical regions. Understanding this sequential involvement is crucial for early diagnosis and intervention. [@mckeith2017]

Early-Stage Involvement

The entorhinal cortex and hippocampus are the first regions affected in Alzheimer's disease, accounting for the early memory deficits that characterize the condition. The entorhinal cortex serves as the major gateway between the hippocampus and neocortex, and its degeneration disrupts memory consolidation. The hippocampus, critical for forming new memories, shows early tau pathology in the CA1 region and subiculum. [@rascovsky2011]

The amygdala is involved early in AD, contributing to emotional dysregulation and the psychological and behavioral symptoms of dementia. Amyloid and tau pathology accumulate in the amygdala alongside hippocampal involvement. [@hglinger2017]

Moderate-Stage Involvement

As AD progresses, involvement extends to the temporal lobe regions beyond the hippocampus, including the parahippocampal gyrus and inferior temporal cortex. This progression correlates with worsening memory deficits and the emergence of language difficulties.

The cingulate cortex shows metabolic decline and structural atrophy in moderate AD, contributing to apathy and behavioral changes. The anterior cingulate is particularly vulnerable.

Late-Stage Involvement

In advanced AD, the disease spreads to frontal lobes and parietal lobes, producing the global cognitive impairment seen in later stages. The prefrontal cortex involvement contributes to executive dysfunction, while parietal lobe damage produces visuospatial deficits.

Parkinson's Disease

Parkinson's disease primarily affects subcortical structures, with the characteristic motor symptoms reflecting degeneration of specific nuclei and their connections.

Substantia Nigra

The substantia nigra pars compacta is the hallmark region affected in Parkinson's disease, with loss of dopaminergic neurons producing the motor symptoms of tremor, bradykinesia, and rigidity. The ventral tegmental area, adjacent to the substantia nigra, is also affected, contributing to non-motor symptoms.

Brainstem Nuclei

The locus coeruleus (noradrenergic) and raphe nuclei (serotonergic) are affected early in PD, contributing to depression, sleep disorders, and autonomic dysfunction. The dorsal motor nucleus of the vagus shows Lewy body pathology even before motor symptoms appear.

Basal Ganglia

The striatum (caudate nucleus and putamen) shows dopaminergic denervation in PD, underlying the motor deficits. The globus pallidus and subthalamic nucleus become dysfunctional as the disease progresses, contributing to motor fluctuations and dyskinesias with long-term levodopa treatment.

Cortical Involvement

In Parkinson's disease with dementia (PDD), cortical regions become involved, particularly the temporal lobe and prefrontal cortex, producing the cognitive decline characteristic of PDD. The pattern resembles diffuse Lewy body disease.

Dementia with Lewy Bodies

Dementia with Lewy bodies (DLB) shows a distinctive pattern of brain involvement that differentiates it from both AD and PD.

Subcortical Structures

The substantia nigra is affected, though less severely than in PD. The locus coeruleus and raphe nuclei show significant Lewy body pathology.

Cortical Involvement

The temporal lobe, particularly the amygdala and hippocampus, shows Lewy body pathology. The occipital cortex is notably affected, contributing to the visual hallucinations characteristic of DLB. The frontal cortex involvement produces executive dysfunction.

Frontotemporal Dementia

Frontotemporal dementia (FTD) encompasses a group of disorders characterized by selective frontal and/or temporal lobe degeneration.

Behavioral Variant FTD

The prefrontal cortex and anterior cingulate cortex are primarily affected in behavioral variant FTD, producing the characteristic personality changes, disinhibition, and executive dysfunction. The orbitofrontal cortex involvement contributes to impaired decision-making.

Primary Progressive Aphasia

The left temporal lobe and frontal operculum are primarily affected in semantic variant PPA, while the left perisylvian cortex is affected in nonfluent/agrammatic variant. The temporal pole shows early involvement in semantic variant.

Corticobasal Degeneration

Corticobasal degeneration shows asymmetric involvement of the prefrontal cortex, parietal cortex, and basal ganglia, producing the characteristic asymmetric motor symptoms and cortical sensory loss.

Progressive Supranuclear Palsy

Progressive supranuclear palsy (PSP) primarily affects subcortical structures and the frontal lobe.

Brainstem

The midbrain (particularly the colliculi), pons, and medulla show degeneration. The superior colliculus is especially affected, producing the vertical gaze palsy characteristic of PSP.

Basal Ganglia

The globus pallidus, subthalamic nucleus, and striatum are involved, contributing to the parkinsonism and axial symptoms. The red nucleus and dentate nucleus of the cerebellum are also affected.

Cortex

The prefrontal cortex and motor cortex show involvement in later stages, contributing to cognitive decline and motor symptoms.

Huntington's Disease

Huntington's disease produces a characteristic pattern of striatal degeneration that spreads to cortex.

Striatum

The caudate nucleus and putamen show early and severe degeneration, with medium spiny neurons particularly affected. The striatum shows the characteristic neuron loss and gliosis.

Cortex

As HD progresses, the cerebral cortex shows degeneration, particularly in frontal and temporal regions, contributing to cognitive and behavioral symptoms.

Subcortical Structures

The globus pallidus, thalamus, and subthalamic nucleus are involved. The hippocampus shows pathology contributing to memory deficits.

Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) affects both upper and lower motor neurons.

Motor Cortex

The motor cortex shows degeneration of upper motor neurons, with corticospinal tract degeneration.

Brainstem and Spinal Cord

The hypoglossal nucleus, facial nucleus, and ventral horn of the spinal cord show lower motor neuron loss. The bulbar nuclei involvement produces bulbar symptoms.

Frontal Cortex

Frontotemporal involvement occurs in ALS with cognitive impairment, with the prefrontal cortex showing degeneration in some patients.

Multiple System Atrophy

Multiple system atrophy (MSA) affects multiple brain regions, producing the characteristic autonomic failure and motor symptoms.

Striatum and Globus Pallidus

The striatum (caudate and putamen) shows severe degeneration, particularly in the putamen. The globus pallidus is also affected.

Brainstem and Cerebellum

The pontine nuclei, inferior olivary nucleus, and cerebellar cortex are affected, producing the cerebellar ataxia in MSA-C. The locus coeruleus and raphe nuclei show pathology.

Spinal Cord

The autonomic nuclei in the spinal cord are affected, contributing to autonomic dysfunction.

Summary Table

| Disease | Primary Regions | Secondary Regions |
|---------|-----------------|-------------------|
| Alzheimer's Disease | Hippocampus, Entorhinal Cortex | Temporal Lobe, Frontal Cortex, Parietal Lobe |
| Parkinson's Disease | Substantia Nigra, Striatum | Locus Coeruleus, Brainstem Nuclei |
| Dementia with Lewy Bodies | Temporal Cortex, Occipital Cortex | Substantia Nigra, Frontal Cortex |
| Frontotemporal Dementia | Frontal Cortex, Temporal Lobe | Anterior Cingulate, Orbitofrontal |
| Progressive Supranuclear Palsy | Midbrain, Globus Pallidus | Subthalamic Nucleus, Frontal Cortex |
| Huntington's Disease | Caudate Nucleus, Putamen | Cortex, Thalamus |
| Amyotrophic Lateral Sclerosis | Motor Cortex, Ventral Horn | Brainstem Nuclei, Frontal Cortex |
| Multiple System Atrophy | Striatum, Pons | Cerebellum, Inferior Olivary Nucleus |

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Brain Atlas Resources

Allen Mouse Brain Atlas

• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Comprehensive gene expression and anatomical data for the mouse brain

BrainSpan Atlas

• [BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/): Developmental brain transcriptome data

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
• [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: TREM2
• [Targeted Butyrate Supplementation for Microglial Phenotype Modulation](/hypothesis/h-3d545f4e) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: GPR109A
• [Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: GLP1R, BDNF
• [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: TFR1, LRP1, CAV1, ABCB1
• [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: TREM2
• [Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons](/hypothesis/h-2f43b42f) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: C4B
• [Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: TLR4

Related Analyses:

• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) &#x1f504;

Pathway Diagram

The following diagram shows the key molecular relationships involving Brain Region Disease Involvement discovered through SciDEX knowledge graph analysis: